News

The Cryo-EM microscope has taken over as the main method that Priyamvada Acharya, PhD, director of Duke's new federally funded 

Kevin Saunders explains the technology he used when COVID-19 hit, “We thought of creating a vaccine with properties that the current vaccines lacked.”

Another vaccine poised to enter human clinical trials is being developed by biologist Kevin Saunders and colleagues at the Duke Human Vaccine Institute, who 

Dr. Barton Haynes, Director of the Duke Human Vaccine Institute, discusses the links between COVID and finding a vaccine for HIV. Read about it in this Mother Jones article.

Researchers at the Duke Human Vaccine Institute (DHVI) received a federal grant totaling more than $27 million over five years to focus on building st